Skip to main content
. 2020 Nov 12;10:588862. doi: 10.3389/fonc.2020.588862

Figure 3.

Figure 3

Frequencies of SRE before and after the first 12 months of TKI treatment. Percentage and number of global SREs occurred after diagnosis of BM EGFR-mutated lung cancer before and after the first 12 months of TKI treatment, respectively (EGFR, epidermal growth factor receptor; SRE, skeletal related event; BM, bone metastases; TKI, tyrosine kinase inhibitor).